• Something wrong with this record ?

Partnering to change the world for people with haemophilia: 6(th) Haemophilia Global Summit, Prague, Czech Republic, 24-26(th) September 2015

J. Astermark, D. Hart, S. Lobet, J. Blatný, R. d'Oiron, G. Kenet, G. Dolan, V. Libotte, C. Hermans,

. 2016 ; 97 Suppl 84 (-) : 3-23.

Language English Country England, Great Britain

Document type Congress

Persistent link   https://www.medvik.cz/link/bmc17013780

The 6(th) Haemophilia Global Summit was held in Prague, Czech Republic, in September 2015. The programme was designed by an independent Scientific Steering Committee of haemophilia experts and aimed to share optimal management strategies for haemophilia at all life stages, explore recent potential advances in the management of haemophilia A and B and discuss challenges in haemophilia care. In this supplement from the meeting, Dan Hart reviews the lessons that can be learnt from cost-constrained environments with regard to improving care for people with haemophilia globally. Sébastien Lobet discusses the importance of physical activity for optimising care and Roseline d'Oiron and Jan Blatný consider the role of real-world data in understanding the effect of treatment in a clinical setting over the long term and the true impact of treatment on the day-to-day life of the patient. Gili Kenet addresses the current challenges relating to the optimal management of prophylaxis, and Gerry Dolan and Cedric Hermans discuss the value of pharmacokinetic (PK) parameters in informing treatment decisions. Cedric Hermans and Valérie Libotte explore the importance of considering social and occupational development factors as an integral part of haemophilia care, and Jan Astermark reviews key strategies to predict and prevent inhibitor development.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013780
003      
CZ-PrNML
005      
20200923165108.0
007      
ta
008      
170413s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ejh.12761 $2 doi
035    __
$a (PubMed)27292051
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Astermark, Jan $u Department of Hematology and Vascular Diseases, Skåne University Hospital, Malmö, Sweden. $7 gn_A_00009587
245    10
$a Partnering to change the world for people with haemophilia: 6(th) Haemophilia Global Summit, Prague, Czech Republic, 24-26(th) September 2015 / $c J. Astermark, D. Hart, S. Lobet, J. Blatný, R. d'Oiron, G. Kenet, G. Dolan, V. Libotte, C. Hermans,
520    9_
$a The 6(th) Haemophilia Global Summit was held in Prague, Czech Republic, in September 2015. The programme was designed by an independent Scientific Steering Committee of haemophilia experts and aimed to share optimal management strategies for haemophilia at all life stages, explore recent potential advances in the management of haemophilia A and B and discuss challenges in haemophilia care. In this supplement from the meeting, Dan Hart reviews the lessons that can be learnt from cost-constrained environments with regard to improving care for people with haemophilia globally. Sébastien Lobet discusses the importance of physical activity for optimising care and Roseline d'Oiron and Jan Blatný consider the role of real-world data in understanding the effect of treatment in a clinical setting over the long term and the true impact of treatment on the day-to-day life of the patient. Gili Kenet addresses the current challenges relating to the optimal management of prophylaxis, and Gerry Dolan and Cedric Hermans discuss the value of pharmacokinetic (PK) parameters in informing treatment decisions. Cedric Hermans and Valérie Libotte explore the importance of considering social and occupational development factors as an integral part of haemophilia care, and Jan Astermark reviews key strategies to predict and prevent inhibitor development.
650    _2
$a management nemoci $7 D019468
650    _2
$a hemofilie A $x prevence a kontrola $x terapie $7 D006467
650    _2
$a hemofilie B $x prevence a kontrola $x terapie $7 D002836
650    _2
$a lidé $7 D006801
651    _2
$a Česká republika $7 D018153
655    _2
$a kongresy $7 D016423
700    1_
$a Hart, Dan $u The Royal London Hospital Haemophilia Centre, Barts and The London School of Medicine and Dentistry, QMUL, London, UK.
700    1_
$a Lobet, Sébastien $u Haemostasis and Thrombosis Unit, Division of Haematology, Haemophilia Clinic, Saint-Luc University Hospital, Brussels, Belgium.
700    1_
$a Blatný, Jan $u Children's University Hospital Brno, Brno, Czech Republic.
700    1_
$a d'Oiron, Roseline $u Hôpital Bicêtre AP-HP, Paris XI University, Le Kremlin-Bicêtre, France.
700    1_
$a Kenet, Gili $u National Hemophilia Center, Sheba Medical Center, Tel HaShomer, Israel.
700    1_
$a Dolan, Gerry $u St Thomas' Hospital, London, UK.
700    1_
$a Libotte, Valérie $u Service externe de prévention et de protection au travail - CESI - 1200 Brussels, Belgium.
700    1_
$a Hermans, Cedric $u Catholic University of Louvain, Brussels, Belgium.
773    0_
$w MED00001620 $t European journal of haematology $x 1600-0609 $g Roč. 97 Suppl 84, č. - (2016), s. 3-23
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27292051 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20200923165105 $b ABA008
999    __
$a ok $b bmc $g 1200245 $s 974558
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 97 Suppl 84 $c - $d 3-23 $i 1600-0609 $m European journal of haematology $n Eur J Haematol $x MED00001620
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Archiving options